Jiadai Xu

4PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 11, 2026
The efficacy, safety, and rationale of orelabrutinib combined with obinutuzumab (O2) as a first-line systemic treatment for marginal zone lymphoma.

|Aug 09, 2020
Suppression of CXCL-1 Could Restore Necroptotic Pathway in Chronic Lymphocytic Leukemia.

Zhao Xu, Yifeng Sun, Zheng Wei

|Jun 11, 2020
The paradoxical prognostic role of 1q21 Gain/Amplification in multiple myeloma: every coin has two sides.

Jiadai Xu, Tianhong Xu, Yang Yang

|Jan 29, 2019
A Novel Scoring System Based on the Level of HDL-C for Predicting the Prognosis of t-DLBCL Patients: A Single Retrospective Study.

Jiadai Xu, Zheng Wei, Yian Zhang

Pageof 1

Frequent Collaborators

3 joint publications

Peng Liu

2 joint publications

Chen Chen

2 joint publications

Zheng Wei

1 joint publications

Tianhong Xu